Livmarli

Maralixibat chloride, sold under the brand name Livmarli, is a medication used to treat cholestatic pruritus in people with Alagille syndrome.[1] Maralixibat chloride is an ileal bile acid transporter (IBAT) inhibitor.[1] Maralixibat was approved for medical use in the United States in September 2021.[1][2][3] Contents 1 History 2 Names 3 References 4 External links History Maralixibat was granted orphan dr... [wikipedia]